Johnson & Johnson Commits $500 Million Investment Over Four Years to Help End the Epidemics of HIV and Tuberculosis
October 04, 2019
October 04, 2019
NEW BRUNSWICK, New Jersey, Oct. 4 -- Johnson and Johnson issued the following news release:
Johnson & Johnson today announced it has committed to ensuring more than $500 million is dedicated to world class research & development and delivery programs over the next four years to accelerate global efforts to eliminate HIV and tuberculosis (TB) by 2030. As one of the world's largest healthcare companies, Johnson & Johnson is deeply engaged in global health innovation, . . .
Johnson & Johnson today announced it has committed to ensuring more than $500 million is dedicated to world class research & development and delivery programs over the next four years to accelerate global efforts to eliminate HIV and tuberculosis (TB) by 2030. As one of the world's largest healthcare companies, Johnson & Johnson is deeply engaged in global health innovation, . . .